Yahoo
OTC Markets OTCPK - Delayed Quote USD

Nouveau Life Pharmaceuticals, Inc. (NOUV)

0.0001 0.0000 (0.00%)
At close: October 29 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for NOUV
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0001 x --
  • Ask 0.0001 x 12359560700
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0001
  • Volume 100,000
  • Avg. Volume 0
  • Market Cap (intraday) 666,096
  • Beta (5Y Monthly) -75.88
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and artificial intelligence (AI)-based healthcare devices and wearables. The company was formerly known as Gondwana Energy, Ltd. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 1998. The company was incorporated in 1998 and is based in Los Angeles, California. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of Seniorgo.ai.

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NOUV
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

NOUV
900.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

NOUV
50.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

NOUV
95.45%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -19.83%

  • Return on Equity (ttm)

    -219.52%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -503.31k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.1k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    101.54k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: